China's landscape in oncology drug research: perspectives from research collaboration networks

H You; Michael Barber; Thomas Scherngell; J Ni; Yuanjia Hu

doi:10.3978/j

China's landscape in oncology drug research: perspectives from research collaboration networks

H You
, Michael Barber
, Thomas Scherngell
, J Ni
, Yuanjia Hu

Center for Innovation Systems and Policy

University of Macau

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	138-147
Number of pages	10
Journal	Chinese Journal of Cancer Research
Volume	27
Issue number	2
DOIs	https://doi.org/10.3978/j
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Field

Former Research Field - Innovation Systems and Policy

Keywords

anti-cancer
pharmaceuticals
publications
research collaboration

Access to Document

10.3978/jLicence: Unspecified

Cite this

@article{2c652b9cc71944b398bb0d1bda0760f5,

title = "China's landscape in oncology drug research: perspectives from research collaboration networks",

keywords = "anti-cancer, pharmaceuticals, publications, research collaboration, anti-cancer, pharmaceuticals, publications, research collaboration",

author = "H You and Michael Barber and Thomas Scherngell and J Ni and Yuanjia Hu",

year = "2015",

doi = "10.3978/j",

language = "English",

volume = "27",

pages = "138--147",

number = "2",

}

TY - JOUR

T1 - China's landscape in oncology drug research: perspectives from research collaboration networks

AU - You, H

AU - Barber, Michael

AU - Scherngell, Thomas

AU - Ni, J

AU - Hu, Yuanjia

PY - 2015

Y1 - 2015

KW - anti-cancer

KW - pharmaceuticals

KW - publications

KW - research collaboration

KW - anti-cancer

KW - pharmaceuticals

KW - publications

KW - research collaboration

U2 - 10.3978/j

DO - 10.3978/j

M3 - Article

SN - 1000-9604

VL - 27

SP - 138

EP - 147

JO - Chinese Journal of Cancer Research

JF - Chinese Journal of Cancer Research

IS - 2

ER -